Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$497.30
+0.7%
$569.42
$364.17
$616.00
$177.13B1.431.42 million shs2.56 million shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+0.73%-12.45%-16.52%-8.71%+27.71%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
4.5654 of 5 stars
3.43.00.04.03.02.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.71
Moderate Buy$613.1023.28% Upside

Current Analyst Ratings Breakdown

Latest ISRG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
1/27/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
CICC Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$550.00
1/27/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$490.00 ➝ $530.00
1/27/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$500.00 ➝ $560.00
1/27/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$490.00 ➝ $548.00
1/27/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$611.00 ➝ $641.00
1/27/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$475.00 ➝ $575.00
1/27/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Bernstein Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$655.00 ➝ $700.00
1/27/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price Target$610.00 ➝ $674.00
1/24/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$640.00 ➝ $666.00
1/24/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$560.00 ➝ $688.00
(Data available from 3/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$8.35B21.21$6.55 per share75.93$46.41 per share10.72
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.32B$6.4177.5865.185.8527.81%14.55%12.88%4/17/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.07
3.22

Institutional Ownership

CompanyInstitutional Ownership
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%

Insider Ownership

CompanyInsider Ownership
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
15,638356.18 million352.97 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$497.30 +3.58 (+0.73%)
Closing price 03/12/2025 04:00 PM Eastern
Extended Trading
$497.66 +0.36 (+0.07%)
As of 03/12/2025 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.